I think this says a lot of it: Are we one of those 5 targets?...

I think this says a lot of it: Are we one of those 5 targets? yes, because we have filed for nero covid patentS. sounds like we got in first with the IP and now we ask who's coughing up the most to collab with? correct me if wrong.

Certain targets when combined (as few as 5) identified all 48 Neuro Covid-19 patients and the 42 of
44 subjects who were convalescent or healthy controls suggestive of these targets’ diagnostic potential. A
number of targets (<15) have been identified as potentially amenable to treatment by currently available
drugs or other therapeutic approaches on the market. The mechanisms of action of those drugs are known
to modulate the discovered target proteins, therefore the marketers/developers of those drugs have been
identified as initial prospects for partnering interest. A smaller number of diagnostic markers have been
detected that could assist in the identification of Neuro Long Covid patients for better designed clinical trials
and potentially for earlier treatment intervention. Accordingly, the Company also plans to review its newly
generated intellectual property (IP) with targeted pharmaceutical and diagnostic companies for potential
commercial discussions, noting that for these discussions to progress, the Company and potential partner
companies would need to agree on licensing and/or joint development of this newly generated IP to advance
as either diagnostic or therapeutic programs.